ABM
PrivateLast Round
Series B
Extension
May 4, 2023
Total Funding Raised
$50M
Momentum Score
25 /100
Company Overview
Abmtx is a biotechnology company specializing in pharmaceutical solutions for brain, lung, and breast cancers, focusing on suppressing tumor growth and metastasis to enhance treatment efficacy for patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ABM Comps
Public and private peers based on sector, stage, and business model.
ABM Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 4, 2023 | ||||
| Series B | Jan 4, 2022 | ||||
| Series A Extension | Aug 7, 2020 |
ABM Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| Baidu Ventures | Series B |
| Photon Fund | Series B |
| Sincere Capital | Series B |
| Jiangsu Honghui Equity Investment Management | Series B |
| Kaitai Capital | Series A Extension |
| 健壹资本 | Series A Extension |
ABM Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ABM's valuation, stock price, and market status.
